Nutrien Q3 Earnings Flat YoY; Lack of Phosphate Update Pressures Thesis

What happened

Nutrien reported Q3 2026 net earnings of $0.29 billion ($0.60 diluted EPS) and adjusted EBITDA of $1.31 billion, with first nine months net earnings of $1.65 billion and adjusted EBITDA of $4.85 billion. While management highlighted 'structural earnings growth and increased cash returns,' the figures show that net earnings are roughly flat compared to the same period in 2025 (nine-month net earnings of approximately $1.7 billion in 2025). The Q3 adjusted EBITDA of $1.31 billion suggests a sequential slowdown from the first half, when Q1 and Q2 combined for $3.54 billion, likely reflecting softer potash prices or volumes than the bullish scenarios anticipated. The press release does not provide segment details or an update on the phosphate strategic alternatives review, which was a key catalyst for the DeepValue thesis. Without evidence of potash volume strength or a phosphate transaction, the earnings print appears to undermine the base-case assumptions of $80 implied value.

Implication

The earnings miss (relative to the implied trajectory needed for $80 base case) suggests that potash pricing may be tracking the bear scenario of $50/tonne below plan, which would compress full-year adjusted EBITDA to around $5.5-6.0 billion and support a valuation near $62. The absence of a phosphate strategic update eight months into 2026 is a red flag; management had committed to 'solidify the optimal path in 2026,' and the longer the delay, the lower the probability of a value-accretive transaction by year-end. Retail performance remains opaque, but if Brazil continues to defer purchases, the $1.75-1.95 billion Retail EBITDA guidance for 2026 may be at risk. Investors should monitor Q4 potash volumes and any announcement on phosphate; without a catalyst, the stock is likely to drift toward the bear-case scenario. Consider reducing exposure if Q4 does not show a rebound in potash shipments or a concrete phosphate decision.

Thesis delta

The previous 'Potential Buy' thesis relied on 2026 potash volumes of 14.1-14.8 Mt and a 2026 phosphate strategic-alternatives outcome. Q3 2026 results show flat year-over-year earnings and no phosphate update, indicating that both pillars are underperforming or delayed. The bullish scenario probability should be reduced from 20% to below 10%, and the bear scenario probability increased from 25% to at least 35%, shifting the expected value toward $68-70 while retaining some upside if catalysts materialize.